Why the study?
Do angiopoietin-like proteins regulate lipoprotein metabolism and affect cardiovascular events?
Do angiopoietin-like proteins regulate lipoprotein metabolism and affect cardiovascular events?
Angptl3, Angptl4, and Angptl5 are important regulators of lipoprotein metabolism, highlighting their potential as therapeutic targets for dyslipidemia and cardiovascular disease prevention.
Answers are grounded in this paper and cite their sources.
May guide ANGPTL inhibitor development for hypertriglyceridemia; leaves open cardiovascular event reduction in trials.
PURPOSE OF REVIEW: Angiopoietin-like proteins (Angptls) comprise a family of secreted glycoproteins with high homology to angiopoietins which are important regulators of angiogenesis. Angptl3 and Angptl4 inhibit lipoprotein lipase in mice. This article reviews recent human studies on Angptls and their effects on lipoprotein profiles and cardiovascular disease. RECENT FINDINGS: Population-based studies have indicated that loss-of-function mutations of Angptl3, Angptl4, and Angptl5 are associated with a low triglyceride concentration. Angptl3 concentration is positively correlated with HDL-cholesterol, but not with triglyceride, suggesting that Angptl3 regulates HDL metabolism by inhibiting endothelial lipase. Angptl4 concentration is correlated positively with triglycerides in patients with metabolic syndrome, although most studies have failed to find such a correlation. Angptl6 has no effects on lipoprotein profiles. Angptl3 is associated with atherosclerosis in coronary, carotid, and femoral arteries. Conflicting results have been obtained regarding whether the E40K variant (a loss-of-function mutation of Angptl4) is associated with an increased risk for cardiovascular disease, which may occur due to the lipid-independent actions of Angptl4. SUMMARY: Angptl3, Angptl4, and possibly Angptl5 are regulators of lipoprotein metabolism in humans. Whether inhibition of these Angptls will be useful for dyslipidemia to prevent cardiovascular disease remains to be elucidated in future studies.
No takes yet. Share an insight, caveat, or question.
Miida et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: